Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 12/20 | 0.40 |
| ▸ | CCR1 | P32246 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2365286 | 0.90 | FAAH (0.41) | FAAHCCR1GAACXCR3KDM4E | |
| SCHEMBL15230566 | 0.89 | FAAH (0.40) | FAAHCCR1CXCR3 | |
| SCHEMBL16534441 | 0.88 | FAAH (0.41) | FAAH | |
| SCHEMBL120216 | 0.84 | FAAH (0.49) | FAAH | |
| SCHEMBL123112 | 0.84 | FAAH (0.49) | FAAH | |
| SCHEMBL14908866 | 0.84 | FAAH (0.49) | FAAH | |
| SCHEMBL118625 | 0.84 | FAAH (0.49) | FAAH | |
| SCHEMBL15231469 | 0.84 | FAAH (0.42) | FAAHCCR1GAACXCR3KDM4E | |
| SCHEMBL15231293 | 0.83 | FAAH (0.40) | FAAHCCR1GAAKDM4EPOLB | |
| SCHEMBL15230099 | 0.83 | FAAH (0.40) | FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150065481-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2015-03-05 | — | — | US | disclosed |
| EP-2820011-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | Syngenta Participations AG (CH) | 2015-01-07 | — | — | EP | disclosed |
| WO-2013127789-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2013-09-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150065481-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | PRF1, CASP1, MPO | FAAH 1071/4885CCR1 102/4885GAA 2082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.